載入...
A New Age for Vaccine Therapy in Renal Cell Carcinoma
Over the past several years, the dominant paradigm in drug development for metastatic renal cell carcinoma (mRCC) has been to more selectively and potently target moieties such as the vascular endothelial growth factor receptor (VEGFR). The effectiveness of this strategy appears to be nearing a plat...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3845885/ https://ncbi.nlm.nih.gov/pubmed/23867519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e31829d74b4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|